NANOMEDNanomedicine for Drug DeliveryCourses Description: This 24 months, 120 ECTS Master’s Course in English offers a high quality and multidisciplinary education in the emerging field of NANOMEDICINE. The consortium is composed of four Universities: Paris-Descartes (Fr, coordinator), Patras (Gr), Pavia (It) and Angers (Fr).Nanomedicine is a revolutionary interdisciplinary science, combining knowledge from Physics, Biology, Chemistry and Medicine to treat diseases of the human body. The consortium creates a curriculum bringing together the expertise of four Universities in their respective domains of Nanomedicine. Renowned experts in the field from academia and industry are already involved in the pedagogical staff. The final goal is to achieve the qualification of young scientists with appropriate credentials in order to lead the related field, either in Industry or in Academia. Each student will receive a Triple Master Degree corresponding to three diplomas issued by different Universities according to the mobility pathway. In the Basic Nanomedicine part (S1), the training in Patras or Paris consists in basic pharmaceutical technology (Biopharmacy, formulation, production, controls). This first level provides the essential knowledge necessary to work in Pharmaceutical domains and to introduce innovative drug delivery system as used in Nanomedicine. Specific courses on chemistry or biology will be proposed for students from science background who are non-pharmacist. In S2 all students will follow practical courses in Paris on drug delivery systems and colloidal carriers. A 3-months internship in full partners’ laboratories will close S2. It gives each participating student the opportunity to share a common background in Drug Delivery and a serious introduction in Nanomedicine. The Advanced Nanomedicine part of the curriculum (S3) corresponds to the specialization of students by choosing a training option according to their professional project. In Pavia, S3 will be dedicated to the “Production and Applications of Nanomedicine” providing students with in-depth knowledge on different applications of nanoparticles and production, regulations and quality by design. In Angers, “Strategy of Nanomedicine Development for Clinical Application” is training professionals to manage innovative research projects with skills in Nanomedicine transfer from research to clinical applications. During the final internship period (S4, 6 months), students apply this new knowledge to the successful achievement of research and development projects on Nanomedicine in either an academic team recognized by Industrials or selected private companies which will be full and associated partners of this consortium.Application requirements will include the completion of a Bachelor’s degree in Pharmacy, or (under special provisions) in Chemistry, Biology, Biochemistry, Material Sciences or other adequate discipline. English language proficiency is also required.